Material Detail
Eli Lilly's Project Resilience: Anticipating the Future of the Pharmaceutical Industry
This "case describes changes facing the structure of the pharmaceutical industry as a result of new science and untenable cost structures and options Eli Lilly is considering on how to alter its business model to capitalize on those changes." The Learning Objective is "to introduce students to the issues inherent in 'making strategy' in terms of very significant environmental turbulence -- to introduce them to the strengths and weaknesses of scenario planning as a tool, and to give them practice in making strategic choices."
Quality
-
User Rating
- Comments
- Learning Exercises
- Bookmark Collections
- Course ePortfolios
- Accessibility Info
More about this material
- Material Type:
- Case Study
- Date Added to MERLOT:
- January 27, 2009
- Date Modified in MERLOT:
- December 5, 2017
- Author:
- Rebecca Henderson, MIT Sloan School of Management
- Submitter:
-
Cathy Swift
- Primary Audience:
- College Upper Division, Graduate School, Professional
- Technical Format:
- Other
- Mobile Compatibility:
- Not specified at this time
- Technical Requirements:
- Download case from this site
- Language:
- English
- Cost Involved:
- No
- Source Code Available:
- Unknown
- Creative Commons:
-
This work is licensed under a Attribution-NonCommercial-ShareAlike 3.0 United States
